
Obesity surgery—weight loss, metabolic changes, oncological effects, and follow-up
Author(s) -
Jodok Fink,
Gabriel Seifert,
Matthias Blüher,
Stefan FichtnerFeigl,
Goran Marjanović
Publication year - 2022
Publication title -
deutsches ärzteblatt international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 60
ISSN - 1866-0452
DOI - 10.3238/arztebl.m2021.0359
Subject(s) - medicine , obesity , weight loss , incidence (geometry) , sleeve gastrectomy , type 2 diabetes , surgery , diabetes mellitus , gastric bypass , endocrinology , physics , optics
In 2017, the prevalence of obesity (BMI ≥= 30 kg/m2) in Germany was approximately 16%. Obesity increases an individual's risk of developing type 2 diabetes (T2DM) and arterial hypertension; it also increases overall mortality. Consequently, effective treatment is a necessity. Approximately 20 000 bariatric operations are performed in Germany each year.